Summary
Aortic strips from atherosclerotic rabbits or Achilles tendons from healthy rabbits were superfused with blood (3 ml/min) from anaesthetized and heparinized cats, while blood was returned to the venous system of animals. The superfused tissues gained in weight because of deposition of platelet thrombi on their surface. This gain in weight was continuously monitored and quantified. Forty minutes after intravenous administration of indomethacin (14 mg/kg), aspirin (7 mg/kg) or nictindole (2 mg/kg) the formation of platelet deposits was reduced by half. Three hours after i.v. administration of each drug at a dose of 20 mg/kg the remaining anti-platelet activities were 92% for aspirin, 59% for indomethacin and 18% for nictindole as compared to their antithrombotic action, which was recorded 40 min after their administration. Thrombogenesis was also prevented by a direct infusion of nictindole (50 ng/ml) or indomethacin (2000 ng/ml) into a stream of superfusing blood. Thereby our method enables us to quantify in vivo anti-aggregating potency of drugs, to estimate the duration of this action, and to compare their in vitro and in vivo aggregation-inhibitory activities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aznar, J., Jimenez, C., Villa, P.: A technique for evaluation of platelet-collagen adhesiveness in vitro. Haemostasis5, 318–327 (1976)
Balleisen, L., Marx, R., Kühn, K.: Platelet-collagen interaction. The influence of native and modified collagen (type I) on the aggregation of human platelets. Haemostasis5, 155–164 (1976)
Baumgartner, H. R.: The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc. Res.5, 167–179 (1973)
Baumgartner, H. R.: Effects of anticoagulation on the interaction of human platelets with subendothelium in flowing blood. Schweiz. Med. Wochenschr.106, 1367–1368 (1976)
Flower, R. J., Gryglewski, R., Herbaczyńska-Cedro, K., Vane, J. R.: Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nature New Biol.238, 104–106 (1972)
Gaut, Z. N., Baruth, H., Randal, L. O., Ashley, C., Paulsrud, J. R.: Stereoisomeric relationship among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetase. Prostaglandins10, 59–66 (1975)
Gryglewski, R.: Prostaglandin and thromboxane biosynthesis inhibitors. Naunyn-Schmiedeberg's Arch. Pharmacol.297, S85-S88 (1977a)
Gryglewski, R.: Screening for inhibitors of prostaglandin and thromboxane biosynthesis. In: Prostaglandins and thromboxanes (F. Berti, B. Samuelsson and G. P. Velo, eds), pp. 85–110, New York-London: Plenum Press 1977b
Gryglewski, R., Bunting, S., Moncada, S., Flower, R. J., Vane, J. R.: Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins12, 685–713 (1976)
Gryglewski, R., Zmuda, A., Korbut, R., Krocioch, E., Bieroń, K.: Selective inhibition of thromboxane A2 biosynthesis in blood platelets. Nature267, 627–630 (1977)
Hamberg, M., Svensson, J., Samuelsson, B.: Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. U.S.A.72, 2994–2998 (1975)
Hornstra, G.: A method for the determination of thrombocyte aggregation in circulating rat blood. Experientia26, 111–112 (1969)
Hornstra, G., Gielen, S. Y.: Measurement of platelet aggregation in flowing blood with the use of a filter. Path. Biol.22, 11–16 (1974)
Maekawa, T., Kobayashi, N., Arai, H., Takeuchi, T.: Role of blood platelets in the formation of thrombus. Thrombosis Res., Suppl. II,8, 227–234 (1976)
Moncada, S., Gryglewski, R., Bunting, S., Vane, J. R.: An enzyme isolated from arteries transfoms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature263, 663–665 (1976)
Mustard, J. F., Packham, M. A.: Platelets, thrombosis and drugs. Drugs9, 19–76 (1975)
Patrono, C., Ciabattoni, G., Grossi-Belloni, D.: Release of prostaglandin F1 alpha and F2 alpha from superfused platelets: Quantitive evaluation of the inhibitory effects of some aspirin-like drugs. Prostaglandins9, 557–567 (1975)
Patrono, C., Ciabattoni, G., Greco, F., Grossi-Belloni, D.: Comparative evaluation of the inhibitory effects of aspirin-like drugs on prostaglandin production by human platelets and synovial tissue. In: Advances in Prostaglandin and Thromboxane Research, Vol. 1, pp. 125–131 (B. Samuelsson and R. Paoletti, eds.). New York: Raven Press, 1976
Proudlock, J. W., Day, J.: Cholesterol esterifying enzymes of atherosclerotic rabbit intima. Biochem. Biophys. Acta260, 716–723 (1972)
Scriabine, A.: Platelets and platelet aggregation inhibitors. In: Cardiovascular Pharmacology (M. Antonaccio, ed.), pp. 429–459. New York: Raven Press, 1977
Weber, A. J., Johnson, S. A.: Platelet participation in blood coagulation. Aspect of hemostasis. Am. J. Path.60, 19–42 (1970)
Zirinis, P.: Effect of prostaglandin synthesis inhibitors in rats, measured by filtration pressure on arachidonic acid treated blood. Pharmacol. Res. Commun.7, 535–543 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gryglewski, R.J., Korbut, R., Ocetkiewicz, A. et al. In vivo method for quantitation of anti-platelet potency of drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 302, 25–30 (1978). https://doi.org/10.1007/BF00586592
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00586592